Home
Nexcelom Bioscience, LLC

Nexcelom Bioscience, LLC Market Share Analysis for January 2026

we provide health science technologies, expertise, and services that deliver complete workflow solutions from target to cure.

Science and Education > Biology

Domainnexcelom.com

Year Founded2003

Employees51 - 200

Annual Revenue$15M - $25M

Nexcelom Bioscience, LLC

Nexcelom Bioscience, LLC (including company regionals)

nexcelom.com

See more website traffic and engagement information

Nexcelom Bioscience, LLC Revenue up to January 2026 is 15M - 25M

revenue generated by Nexcelom Bioscience, LLC top domains

Nexcelom Bioscience, LLC top domains revenue over 3 years

Revenue for Nexcelom Bioscience, LLC top domains

nexcelom.com15M - 25M

See more with Sales Intelligence

Total visits to Nexcelom Bioscience, LLC's top domains

Understand Nexcelom Bioscience, LLC market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Nexcelom Bioscience, LLC's top domains

Analyze Nexcelom Bioscience, LLC engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Nexcelom Bioscience, LLC's top domains

See how Nexcelom Bioscience, LLC keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Nexcelom Bioscience, LLC top competitors by domain

Top similar sites in January 2026, ranked by their affinity

lifetechnologies.comCompany NameLife TechnologiesEmployees1001 - 5000HQUnited States, California, CarlsbadAnnual revenue> $1BTotal visits--Science and Education > Biology

Top technologies used by Nexcelom Bioscience, LLC

These are the website technologies, by industry, used by Nexcelom Bioscience, LLC top domains

Payment & Currencies (10)

Cart Functionality

Advertising (6)

DoubleClick

eCommerce (6)

OpenCart

Social (6)

Instagram

More Technologies

14

See all

News & Signals from Nexcelom Bioscience, LLC

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPerkinElmer acquired Nexcelom for $260M on May 1st '21.In May 2021, PerkinElmer inked a deal to acquire Nexcelom Bioscience for an amount of $260 million in cash.

NewsNexcelom launches Cellaca MX. The Cellaca MX.Nexcelom Bioscience, a leading provider of cell counting and characterization products for the life science industry, announced the launch of the revolutionary high throughput, high-speed automated cell counter – Cellaca™ MX. The Cellaca™ MX utilizes Nexcelom’s innovative cellular analysis technology for accurate cell sample concentration, viability and morphology measurements.

NewsAmpersand Capital invested into Nexcelom on Mar 20th '18.Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry, announced today that it has received a strategic investment from Ampersand Capital Partners.